162 related articles for article (PubMed ID: 29056740)
1. The Use of Recombinant Feline Interferon Omega Therapy as an Immune-Modulator in Cats Naturally Infected with Feline Immunodeficiency Virus: New Perspectives.
Leal RO; Gil S
Vet Sci; 2016 Oct; 3(4):. PubMed ID: 29056740
[TBL] [Abstract][Full Text] [Related]
2. Oral Recombinant Feline Interferon-Omega as an alternative immune modulation therapy in FIV positive cats: clinical and laboratory evaluation.
Gil S; Leal RO; McGahie D; Sepúlveda N; Duarte A; Niza MM; Tavares L
Res Vet Sci; 2014 Feb; 96(1):79-85. PubMed ID: 24332273
[TBL] [Abstract][Full Text] [Related]
3. Feline immunodeficiency virus lacks sensitivity to the antiviral activity of feline IFN-gamma.
Tanabe T; Yamamoto JK
J Interferon Cytokine Res; 2001 Dec; 21(12):1039-46. PubMed ID: 11798461
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic effects of recombinant feline interferon-omega on feline leukemia virus (FeLV)-infected and FeLV/feline immunodeficiency virus (FIV)-coinfected symptomatic cats.
de Mari K; Maynard L; Sanquer A; Lebreux B; Eun HM
J Vet Intern Med; 2004; 18(4):477-82. PubMed ID: 15320583
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of viremia, proviral load and cytokine profile in naturally feline immunodeficiency virus infected cats treated with two different protocols of recombinant feline interferon omega.
Leal RO; Gil S; Duarte A; McGahie D; Sepúlveda N; Niza MM; Tavares L
Res Vet Sci; 2015 Apr; 99():87-95. PubMed ID: 25747956
[TBL] [Abstract][Full Text] [Related]
6. Use of recombinant interferon omega in feline retrovirosis: from theory to practice.
Doménech A; Miró G; Collado VM; Ballesteros N; Sanjosé L; Escolar E; Martin S; Gomez-Lucia E
Vet Immunol Immunopathol; 2011 Oct; 143(3-4):301-6. PubMed ID: 21719116
[TBL] [Abstract][Full Text] [Related]
7. Monitoring acute phase proteins in retrovirus infected cats undergoing feline interferon-ω therapy.
Leal RO; Gil S; Sepúlveda N; McGahie D; Duarte A; Niza MM; Tavares L
J Small Anim Pract; 2014 Jan; 55(1):39-45. PubMed ID: 24279640
[TBL] [Abstract][Full Text] [Related]
8. Cytokine modulation of the innate immune response in feline immunodeficiency virus-infected cats.
Dean GA; LaVoy A; Yearley J; Stanton C
J Infect Dis; 2006 Jun; 193(11):1520-7. PubMed ID: 16652280
[TBL] [Abstract][Full Text] [Related]
9. Pretreatment with feline interferon omega and the course of subsequent infection with feline herpesvirus in cats.
Haid C; Kaps S; Gönczi E; Hässig M; Metzler A; Spiess BM; Richter M
Vet Ophthalmol; 2007; 10(5):278-84. PubMed ID: 17760705
[TBL] [Abstract][Full Text] [Related]
10. Prior Puma Lentivirus Infection Modifies Early Immune Responses and Attenuates Feline Immunodeficiency Virus Infection in Cats.
Sprague WS; Troyer RM; Zheng X; Wood BA; Macmillian M; Carver S; VandeWoude S
Viruses; 2018 Apr; 10(4):. PubMed ID: 29677149
[TBL] [Abstract][Full Text] [Related]
11. Expression of APOBEC3 Lentiviral Restriction Factors in Cats.
Troyer RM; Malmberg JL; Zheng X; Miller C; MacMillan M; Sprague WS; Wood BA; VandeWoude S
Viruses; 2019 Sep; 11(9):. PubMed ID: 31500260
[TBL] [Abstract][Full Text] [Related]
12. Limited efficacy of topical recombinant feline interferon-omega for treatment of cats with acute upper respiratory viral disease.
Ballin AC; Schulz B; Helps C; Sauter-Louis C; Mueller RS; Hartmann K
Vet J; 2014 Dec; 202(3):466-70. PubMed ID: 25457261
[TBL] [Abstract][Full Text] [Related]
13. [Feline immunodeficiency virus infection: interferon gamma secretion in a T-lymphoblastoid infected cell line].
Mórtola EC; Endo Y; Zuccolilli GO; Gimeno EJ
Rev Argent Microbiol; 1999; 31(3):127-34. PubMed ID: 10509391
[TBL] [Abstract][Full Text] [Related]
14. Effect of recombinant feline interferon-omega alone and in combination with chemotherapeutic agents on putative tumour-initiating cells and daughter cells derived from canine and feline mammary tumours.
Penzo C; Ross M; Muirhead R; Else R; Argyle DJ
Vet Comp Oncol; 2009 Dec; 7(4):222-9. PubMed ID: 19891692
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of antiviral chemotherapy for retrovirus-infected cats: What does the current literature tell us?
Hartmann K
J Feline Med Surg; 2015 Nov; 17(11):925-39. PubMed ID: 26486979
[TBL] [Abstract][Full Text] [Related]
16. Effects of incidental infections and immune activation on disease progression in experimentally feline immunodeficiency virus-infected cats.
Reubel GH; Dean GA; George JW; Barlough JE; Pedersen NC
J Acquir Immune Defic Syndr (1988); 1994 Oct; 7(10):1003-15. PubMed ID: 7916048
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the efficacy of the subcutaneous low recombinant feline interferon-omega administration protocol for feline chronic gingivitis-stomatitis in feline calicivirus-positive cats.
Matsumoto H; Teshima T; Iizuka Y; Sakusabe A; Takahashi D; Amimoto A; Koyama H
Res Vet Sci; 2018 Dec; 121():53-58. PubMed ID: 30359811
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant immunotherapy of feline fibrosarcoma with recombinant feline interferon-omega.
Hampel V; Schwarz B; Kempf C; Köstlin R; Schillinger U; Küchenhoff H; Fenske N; Brill T; Hirschberger J
J Vet Intern Med; 2007; 21(6):1340-6. PubMed ID: 18196745
[TBL] [Abstract][Full Text] [Related]
19. A Naturally Occurring Domestic Cat APOBEC3 Variant Confers Resistance to Feline Immunodeficiency Virus Infection.
Yoshikawa R; Izumi T; Yamada E; Nakano Y; Misawa N; Ren F; Carpenter MA; Ikeda T; Münk C; Harris RS; Miyazawa T; Koyanagi Y; Sato K
J Virol; 2016 Jan; 90(1):474-85. PubMed ID: 26491161
[TBL] [Abstract][Full Text] [Related]
20. Current thoughts on feline immunodeficiency virus infection.
Sparger EE
Vet Clin North Am Small Anim Pract; 1993 Jan; 23(1):173-91. PubMed ID: 8380656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
